These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22864455)

  • 1. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.
    Morris S; Baio G; Kendall E; von Wagner C; Wardle J; Atkin W; Halloran SP; Handley G; Logan RF; Obichere A; Rainbow S; Smith S; Snowball J; Raine R
    Br J Cancer; 2012 Aug; 107(5):765-71. PubMed ID: 22864455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
    von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
    Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
    Geraghty J; Butler P; Seaman H; Snowball J; Sarkar S; Blanks R; Halloran S; Bodger K; Rees CJ
    Br J Cancer; 2014 Nov; 111(11):2156-62. PubMed ID: 25225905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test.
    Ferrat E; Le Breton J; Veerabudun K; Bercier S; Brixi Z; Khoshnood B; Paillaud E; Attali C; Bastuji-Garin S
    Br J Cancer; 2013 Sep; 109(6):1437-44. PubMed ID: 23989948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme.
    Mansouri D; McMillan DC; Grant Y; Crighton EM; Horgan PG
    PLoS One; 2013; 8(6):e66063. PubMed ID: 23776606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test.
    Dupont-Lucas C; Dejardin O; Dancourt V; Launay L; Launoy G; Guittet L
    Dig Liver Dis; 2011 Sep; 43(9):714-20. PubMed ID: 21530429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre.
    Padmanabhan H; Widlak M; Nevill A; McKaig B; Brookes M; Veitch A
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1281-5. PubMed ID: 26267240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance measures in three rounds of the English bowel cancer screening pilot.
    Moss SM; Campbell C; Melia J; Coleman D; Smith S; Parker R; Ramsell P; Patnick J; Weller DP
    Gut; 2012 Jan; 61(1):101-7. PubMed ID: 21561880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
    Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
    Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
    Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
    Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.
    Bevan R; Lee TJ; Nickerson C; Rubin G; Rees CJ;
    J Med Screen; 2014 Jun; 21(2):89-94. PubMed ID: 24644029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.